Gain Therapeutics, Inc. Annual Share-based Payment Arrangement, Expense in USD from 2021 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Gain Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2021 to 2023.
  • Gain Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $358K, a 56.2% decline year-over-year.
  • Gain Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $2.58M, a 20.9% decline year-over-year.
  • Gain Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $3.26M, a 114% increase from 2022.
  • Gain Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $1.53M, a 81.9% increase from 2021.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $3.26M +$1.73M +114% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-26
2022 $1.53M +$687K +81.9% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-26
2021 $839K Jan 1, 2021 Dec 31, 2021 10-K 2023-03-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.